Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

Dog with brain cancer treated with stereotactic radiosurgery

Press releases may be edited for formatting or style | May 12, 2016

“Successfully navigating cancer care takes very careful application of best practices in quality assurance, best technology, and highly trained experts to provide the best outcome,” said Mike Jones, R.T. (T), VRIC director of radiation therapy. “Using the same SRS technology with pets that has been effectively utilized for humans for decades has been a game-changer. We are saving lives every day.”

In recognition of May’s Brain Tumor Awareness Month, PetCure Oncology appreciates that brain tumors occur in both humans and pets. Seizures are the most common indication of brain tumors in dogs. Other symptoms may include unusual behavior or temperament, vision problems, movement in circles, uncoordinated movement, unsteady gait, lack of appetite, inappropriate urination, and/or lethargy. While brain tumors in cats are less common, they may display the same symptoms as dogs along with head-pressing and unusual meowing. Seek immediate care for a pet that shows indications of a brain tumor.

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

About PetCure Oncology

PetCure Oncology’s national network of veterinary cancer care centers specializing in SRS includes Arizona Veterinary Oncology in Gilbert, Arizona, Care Center in Cincinnati, Ohio, Veterinary Radiosurgery and Imaging Center in Clifton, New Jersey, and Lakeshore Veterinary Specialists in Milwaukee, Wisconsin. Additional centers across the country are in various stages of development. Visit PetCureOncology.com for more information.

Contacts
JoAnn Stewart, RVT, CVPM - COO, PetCure Oncology
847-275-8600 | jstewart@petcureoncology.com

Back to HCB News

You Must Be Logged In To Post A Comment